These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 25050929)
1. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis. Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929 [TBL] [Abstract][Full Text] [Related]
2. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma. He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785 [TBL] [Abstract][Full Text] [Related]
3. Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124 [TBL] [Abstract][Full Text] [Related]
4. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers. Lima SC; Hernández-Vargas H; Simão T; Durand G; Kruel CD; Le Calvez-Kelm F; Ribeiro Pinto LF; Herceg Z Epigenetics; 2011 Oct; 6(10):1217-27. PubMed ID: 21946330 [TBL] [Abstract][Full Text] [Related]
5. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC). Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239 [TBL] [Abstract][Full Text] [Related]
6. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients. Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140 [TBL] [Abstract][Full Text] [Related]
8. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Ma K; Cao B; Guo M Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma. Sheyhidin I; Hasim A; Zheng F; Ma H Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465 [TBL] [Abstract][Full Text] [Related]
10. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529 [TBL] [Abstract][Full Text] [Related]
11. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas. Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737 [TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma. Kishino T; Niwa T; Yamashita S; Takahashi T; Nakazato H; Nakajima T; Igaki H; Tachimori Y; Suzuki Y; Ushijima T Mol Carcinog; 2016 Dec; 55(12):2077-2088. PubMed ID: 26756304 [TBL] [Abstract][Full Text] [Related]
13. PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma. Pan QF; Li WT; Dong HC; Chen YZ; Yin L; Liu W; Wang WW; Liu D; Li SG; Gu WY; Chen JZ; Yang L; Zhang WJ; Li F Dis Esophagus; 2014; 27(4):396-402. PubMed ID: 23980519 [TBL] [Abstract][Full Text] [Related]
14. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression. Cheng CP; Kuo IY; Alakus H; Frazer KA; Harismendy O; Wang YC; Tseng VS Bioinformatics; 2014 Nov; 30(21):3054-61. PubMed ID: 25015989 [TBL] [Abstract][Full Text] [Related]
15. Screening aberrant methylation profile in esophageal squamous cell carcinoma for Kazakhs in Xinjiang area of China. Chen Y; Yin D; Li L; Deng YC; Tian W Mol Biol Rep; 2015 Feb; 42(2):457-64. PubMed ID: 25304811 [TBL] [Abstract][Full Text] [Related]
16. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073 [TBL] [Abstract][Full Text] [Related]
18. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma. Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829 [TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma. Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]